106.90
+3.44
+(3.32%)
At close: April 11 at 6:43:17 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 7 | 7 |
Avg. Estimate | 4.5B | 4.53B | 17.32B | 17.52B |
Low Estimate | 4.07B | 4.1B | 16.41B | 16.57B |
High Estimate | 5.65B | 5.68B | 17.8B | 18.15B |
Year Ago Sales | 5.44B | 5.14B | 18.93B | 17.32B |
Sales Growth (year/est) | -17.24% | -11.84% | -8.50% | 1.14% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0H68.L | -- | -- | -- | -- |
S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/10/2025 |
Maintains | UBS: Neutral to Neutral | 4/2/2025 |
Maintains | Piper Sandler: Overweight to Overweight | 4/2/2025 |
Maintains | JP Morgan: Neutral to Neutral | 4/2/2025 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 2/28/2025 |
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 2/19/2025 |